Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe

https://doi.org/10.1016/j.yexcr.2004.04.006Get rights and content

Abstract

Human neutrophils are activated by the β-galactoside-binding lectin galectin-3, provided that the cells are primed by in vivo extravasation or by in vitro preactivation with, for example, LPS. Removal of terminal sialic acid can change neutrophil functionality and responsiveness due to exposure of underlying glycoconjugate receptors or change in surface charge. Here, we investigated whether such alteration of the cell surface carbohydrate composition can alter the responsiveness of the cells to galectin-3. Neutrophils were treated with neuraminidases (NA) of different origins: Clostridium perfringens (CP), Salmonella typhimurium, Vibrio cholerae, and Newcastle disease virus (NDV). In the presence of NDV-NA, but no other NA, the otherwise non-responding neutrophils responded readily to galectin-3 by activation of the NADPH-oxidase. The galectin-3 priming effect was inhibited by the sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetyl-neuraminic acid. Earlier studies have shown that priming of the neutrophil response to galectin-3 with, for example, LPS is paralleled by degranulation of intracellular vesicles and granules and upregulation of potential galectin-3 receptors. Also, NDV-NA (but not CP-NA) treatment induced degranulation, shown as an upregulation of complement receptor 3. Since not only the galectin response but also the response to the chemoattractant fMLF was primed, NDV-NA appears to induce a general priming phenomenon, possibly due to receptor upregulation by degranulation.

Introduction

The human defense toward microorganisms is largely dependent on the armory of neutrophil granulocytes, cells that are triggered to generate potent bactericidal (and sometimes tissue destructive) metabolites at the sites of infection [1], [2]. Neutrophil triggering may be mediated by a large number of exogenous, proinflammatory mediators [3], [4] or by endogenous agonists such as C5a (a split product from the complement component C5) or IL-8 (a cytokine of the CXC family) [5], [6]. We have recently added two new proteins, galectin-1 and galectin-3, to the list of endogenous proinflammatory mediators that have the ability to activate neutrophils [7], [8].

The galectin family of proteins is defined by their β-galactoside-binding capacity mediated by their conserved sequence elements in their carbohydrate recognition domain (CRD) [9]. At present, fourteen mammalian galectins have been identified and described [10], [11], [12], [13]. The fact that galectins may be present in the cell cytosol as well as in the nucleus or may be secreted extracellularly, suggests that these proteins exert many different functions. This has also been shown in numerous reports over the last decade [14], [15], [16], [17].

Two of the most extensively studied galectins are galectin-1 and galectin-3. Galectin-1 belongs to the prototype galectins, consisting of a carbohydrate recognition domain (CRD) of 14 kDa that may aggregate into homodimers [9]. Galectin-3 is a 31-kDa chimeric galectin, containing one CRD linked by a collagenase-sensitive domain to an N-terminal aggregating domain that enables the molecule to form homodimers or hexamers [9], [18].

The galectins-1 and -3 activate the neutrophil NADPH-oxidase provided that the cells have first been primed [7], [8], [19], [20]. The priming phenomenon has been described for many settings in neutrophil activation processes, prominent examples being extravasation of the cells from the blood stream to the tissue [21], [22] and the effects of bacterial lipopolysaccharides (LPS) [23] and chemoattractants such as formyl-Met-Leu-Phe (fMLF) [24]. Many priming mechanisms have been suggested and it is reasonable to believe that different mechanisms, alone or in concert, may be the cause of different priming events [23], [25], [26]. A prevailing view is that the mechanism for priming involves alterations of intracellular signaling (e.g., changed levels of various second messengers) and/or directs effects on the NADPH-oxidase [27]. With respect to the priming mechanism in relation to the galectins, we have, however, shown that priming induced by LPS and fMLF, as well as during neutrophil extravasation, is due to mobilization of intracellular granules, a process that endows the plasma membrane with new galectin receptors [7], [8], [19].

An alternative route for galectin priming has recently been suggested by Dias-Baruffi et al. [28] who reported that removal of sialic acid residues from the neutrophil cell surface exposes specific galactose-containing binding structures for galectins [28], [29]. It is well known that polylactosamines (potential galectin-3 receptors) can be masked by sialic acid on various cell surface glycoconjugates, and that desialylation by treatment with neuraminidase, a sialic acid-cleaving enzyme, influences the interaction pattern in several cell–cell or cell–agonist binding events. This is illustrated by the facts that desialylation of mononuclear blood cells promotes growth of HIV-1 [30], and that partial removal of sialic acid from the surface of transformed pancreatic cells increases adhesion as well as cellular aggregation [31], [32].

In this study, we have investigated how neutrophil desialylation primes for galectin-3-induced respiratory burst activity. We found that Newcastle disease virus neuraminidase with specificity for α2-3,8-linked sialic acid (but no other neuraminidase) could prime neutrophils not only for galectin-3 but also for the chemoattractant fMLF. The mechanism behind priming is due to exposure of receptor structures, either by unmasking (sialic acid cleavage) of cell surface receptors or by upregulation of granule stored receptors induced by the sialic acid cleavage.

Section snippets

Preparation of galectin-3

Recombinant human galectin-3 was produced in Escherichia coli (E. coli) and purified as previously described [33]. The lectin was stored at 4°C in phosphate-buffered saline (PBS; pH 7.2) containing lactose (150 mM). When used, the lectin preparation was applied to a gel filtration column (PD10; Pharmacia, Uppsala, Sweden) to remove lactose, and diluted to 400 μg/ml in Krebs–Ringer phosphate buffer-containing glucose (10 mM), Ca2+ (1 mM) and Mg2+ (1.5 mM) (KRG, pH 7.3).

Isolation of neutrophils

Blood neutrophils were

Cleavage of sialic acid from the cell surface by Newcastle disease virus neuraminidase primes neutrophils for galectin-3 activation

To investigate whether removal of sialic acid from the glycoconjugates present on the neutrophil cell surface could effect the response of the cell to galectin-3, neutrophils were first treated with neuraminidases (NA) of four different origins: Clostridium perfringens (CP), Salmonella typhimurium (ST), Vibrio cholerae (VC), and Newcastle disease virus (NDV), chosen based on their differences in specificity (Table 1) [35], [36], [37].

The neutrophils were preincubated with neuraminidase for 15

Discussion

In this paper, we show that alteration of the cell surface carbohydrate composition with neuraminidases can alter the neutrophil functionality and responsiveness, for example, to galectin-3 or fMLF. This alteration is accompanied by (and possibly due to) degranulation. The specificity with which NDV-NA can induce such granule mobilization and receptor upregulation is intriguing and the mechanisms driving this effect have to be further studied.

We have previously shown that neutrophils can

Acknowledgements

This work was supported by the Swedish Medical Research Council, the King Gustaf the V 80-Year foundation, the Swedish Society of Medicine, and the Swedish Foundation for Strategic Research Network of Inflammation Research.

References (53)

  • M. Dias-Baruffi et al.

    Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis

    J. Biol. Chem.

    (2003)
  • N.M. Stamatos et al.

    Desialylation of peripheral blood mononuclear cells promotes growth of HIV-1

    Virology

    (1997)
  • T. Sawada et al.

    Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness

    Biochem. Biophys. Res. Commun.

    (1993)
  • K.R. McLeish et al.

    Azotemia, TNF alpha, and LPS prime the human neutrophil oxidative burst by distinct mechanisms

    Kidney Int.

    (1996)
  • S.D. Freeman et al.

    Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules

    Blood

    (1995)
  • A.L. Cornish et al.

    Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33

    Blood

    (1998)
  • J.G. Cyster et al.

    Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment

    Immunity

    (1997)
  • J.Q. Zhang et al.

    Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes

    J. Biol. Chem.

    (2000)
  • J.I. Gallin et al.
  • I. Goldstein et al.

    Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement

    Proc. Natl. Acad. Sci. U. S. A.

    (1973)
  • M. Baggiolini et al.

    Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1)

    Cytokines

    (1992)
  • J. Almkvist et al.

    Activation of the neutrophil nicotinamide adenine dinucleotide phosphate oxidase by galectin-1

    J. Immunol.

    (2002)
  • D.N. Cooper et al.

    God must love galectins; he made so many of them

    Glycobiology

    (1999)
  • H. Leffler
  • B. Visegrady et al.

    Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)

    Protein Eng.

    (2001)
  • N.L. Perillo et al.

    Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death

    J. Mol. Med.

    (1998)
  • Cited by (23)

    • Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library

      2011, Biochemical Pharmacology
      Citation Excerpt :

      We show that all compounds trigger an activation of the neutrophil NADPH-oxidase in neutrophils primed with TNF-α. These cells are primed, not only in response to the new compounds, but to various inflammatory mediators, chemoattractants, and other ligands [47–50]. The primed response may be a regulatory mechanism, granting a cellular response (such as release of toxic oxygen radicals) only at sites where it is functional and necessary, e.g., in inflamed or infected areas.

    View all citing articles on Scopus
    View full text